Our Pipeline

Targeting Repair of Nervous System Damage

NervGen’s lead drug candidate, NVG-291, has the potential to repair nervous system damage, that occurs as a result of injury or disease. NVG-291 is a close analog to NVG-291-R, which has been used in most preclinical models studying spinal cord injury, multiple sclerosis and other diseases. In the literature, NVG-291-R is commonly referred to as intracellular signaling peptide, or ISP.

Alzheimer's Disease

For more information about NVG-291 and Alzheimer’s disease click here.

Multiple Sclerosis

For more information about NVG-291 and multiple sclerosis click here.

Spinal Cord Injury

For more information about NVG-291 and spinal cord injury click here.